⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 18 in last 7 days 🍎 Food: 180 in last 7 days 🧸 Products: 48 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 4 hours ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 18 in last 7 days 🍎 Food: 180 in last 7 days 🧸 Products: 48 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 4 hours ago
🛡️ EUSW
💊 Medicines 🍎 Food 🧸 Products 🔎 Search
📊 Data
🏷 Brands 🌍 Countries ℹ️ About ✉ Unsubscribe
🇬🇧
🇬🇧 English 🇳🇱 Nederlands 🇫🇷 Français 🇩🇪 Deutsch 🇪🇸 Español 🇮🇹 Italiano 🇵🇹 Português 🇵🇱 Polski 🇸🇪 Svenska 🇷🇴 Română 🇨🇿 Čeština 🇫🇮 Suomi 🇩🇰 Dansk
💊 Medicine AT May 4, 2026

Bupropion Genericon 150 mg Tabletten mit veränderter Wirkstofffreisetzung 150 mg (Tablette mit veränderter Wirkstofffreisetzung)

📷 Wikipedia: Bupropion · Source
Bupropion Genericon 150 mg Tabletten mit veränderter Wirkstofffreisetzung 150 mg (Tablette mit veränderter Wirkstofffreisetzung)
📷 Wikipedia: Bupropion · Source
Bupropion Genericon 150 mg modified-release tablets 150 mg (modified-release tablet) Parallel export ban in effect. Reason: increased additional demand. Marketing authorisation holder: Genericon Pharma Ges.m.b.H., Hafnerstraße 211, 8054 Graz, Austria. Affected packs: 30-count box, bottle [unavailable since 4 May 2026, resupply 22 June 2026]; 7-count box, bottle [available].
⚠️
Shortage ongoing
BUPROPION HYDROCHLORID is currently in short supply in AT.
📈 Timeline
10 days active so far
May 18, 2026 May 27, 2026

What is this? Bupropion Genericon 150 mg is a tablet that slowly releases medicine to help with mood or quitting smoking. It contains bupropion hydrochloride.

What's happening? Some packs of this tablet are not available right now. Only the 7-tablet packs are still in stock.

Does this affect me? If you take this medicine, you might need to check your supply. The shortage is in Austria.

What should I do? Ask your pharmacist or doctor for help finding another pack size or a different medicine.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Active substance(s)
BUPROPION HYDROCHLORID
Agency-published detail

🚫 Parallel export ban active · ATC: N06AX12 · Reason: Erhöhter Mehrbedarf · Marketing authorisation holder: Genericon Pharma Ges.m.b.H., Hafnerstraße 211, 8054 Graz, Österreich · Affected packs: 30 Stück Schachtel, Flasche [Nicht verfügbar, since 2026-05-04, resupply 2026-06-22] · 7 Stück Schachtel, Flasche [verfügbar]

First published
May 4, 2026
Last refreshed by us
16 hours ago
Severity (as classified)
High
Official source
https://medikamente.basg.gv.at/en/medicine-shortage

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

Related alerts

High AT resolved 7 months ago

Bupropion +pharma 150 mg Tabletten mit veränderter Wirkstofffreisetzung 150 mg (Tablette mit veränderter Wirkstofffreisetzung)

Parallel export ban in effect for Bupropion +pharma 150 mg modified-release tablets.
High AT resolved 8 months ago

Bupropion 1A Pharma 150 mg - Tabletten mit veränderter Wirkstofffreisetzung 150 mg (Tablette mit veränderter Wirkstofffreisetzung)

Bupropion 1A Pharma 150 mg modified-release tablets contain 150 mg of the active ingredient.
High AT resolved 11 months ago

Bupropion neuraxpharm 300 mg Tabletten mit veränderter Wirkstofffreisetzung 300 mg (Tablette mit veränderter Wirkstofffreisetzung)

Bupropion neuraxpharm 300 mg modified-release tablets 300 mg (modified-release tablet) Reason: Increased additional need Marketing authorisation holder: neuraxpharm Arzneimittel GmbH, Elisabeth-Selbe...

❓ Frequently asked questions

▸ What is this medicine shortage alert about?
Bupropion Genericon 150 mg Tabletten mit veränderter Wirkstofffreisetzung 150 mg (Tablette mit veränderter Wirkstofffreisetzung). Bupropion Genericon 150 mg modified-release tablets 150 mg (modified-release tablet) Parallel export ban in effect. Reason: increased additional demand. Marketing authorisation holder: Genericon Pharma Ges.m.b.H., Hafnerstraße 211, 8054 Graz, Austria. Affected packs: 30-count bo...
▸ When was this alert issued?
This alert was issued on May 4, 2026 by BASG (Austria).
▸ Which countries are affected?
The alert applies to Austria.
▸ How serious is this alert?
Serious risk. A serious risk means the product or medicine can cause significant harm. Treat the alert as urgent.
▸ What should I do?
If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.
▸ Where can I find the official notice?
The full official notice is published on medikamente.basg.gv.at.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.